Landscapes / Companies
CASI pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
3 active
7 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Nov 2028Phase 2 trial completes | |||
| Next date | 30 Nov 2028 · Phase 2 trial completes | ||||
| Also tested for | Chronic Immune Thrombocytopenia, Antibody Mediated Rejection | ||||
| Open drug page | |||||
About
- No active trial
- ENMD-2076
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021